drugset / Trial / NCT02382809

Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction

NCT02382809 ↗

Phase 4 Completed 414 enrolled Pierre Fabre Laboratories
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to demonstrate the efficacy of 0.2 % digluconate chlorhexidine mouthwash in the prevention of alveolar osteitis following third molar extraction and to evaluate the safety and local tolerability.

Timeline

Start
2015-03
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject DC071 Unknown 0.2 % —

Indications